Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines (Q45734835)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2001

Language	Label	Description	Also known as
English	Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines	scientific article published in October 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

vector-borne disease

0 references

Semliki Forest virus

0 references

8

object named as

Wilschut J

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Withoff S

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Glazenburg KL

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

van Veen ML

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Kraak MM

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Hospers GA

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Störkel S

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

de Vries EG

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Daemen T

9

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1515-1523

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

A Phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Cytokine gene therapy of cancer using interleukin-12: murine and clinical trials.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Intratumoral recombinant GM-CSF-encoding virus as gene therapy in patients with cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Gene therapy for metastatic brain tumors by vaccination with granulocyte-macrophage colony-stimulating factor-transduced tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Regulators of apoptosis on the road to persistent alphavirus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Retrovirus mediated transfer and expression of GM-CSF in haematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Enhancing immune responses using suicidal DNA vaccines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Death mechanisms in cultured cells infected by Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Cancer therapy using a self-replicating RNA vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

The promise of nucleic acid vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Cancer vaccines: the interleukin 2 dosage effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Ex vivo and in vivo adenovirus-mediated gene therapy strategies induce a systemic anti-tumor immune defence in the B16 melanoma model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Initial damage or repair as the major determinant of cellular radiosensitivity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

21 January 2018

Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of non-replicating autologous tumor cell injections using cells prepared with or without GM-CSF gene transduction in patients with metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified Semliki Forest Virus Expression Vector that Facilitates Cloning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301556

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301556

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45734835&oldid=2207287755"